首页 > 最新文献

Current opinion in pediatrics最新文献

英文 中文
Update in new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. 新发难治性癫痫持续状态和发热性感染相关癫痫综合征的最新进展。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-08-20 DOI: 10.1097/MOP.0000000000001501
Pooja D Shah, Heather A Voss-Hoynes, Rachel A Pauley

Purpose of review: New-onset refractory status epileptics (NORSE) and a subset, febrile infection-related epilepsy syndrome (FIRES), are rare clinical presentations with rapid onset, cryptogenic etiology, unpredictable course, and long-standing neurologic sequalae. International consensus recommendations were published in 2022 to aid in diagnosis, treatment, and research of NORSE/FIRES. Subsequently, there have been advances in understanding both the pathophysiology and the efficacy of immunotherapies.

Recent findings: There is growing evidence of immune dysregulation in NORSE/FIRES. Cytokine/chemokine profiles may serve as biomarkers to guide diagnosis and management. The treatment landscape for NORSE/FIRES is evolving, with increasing use of second-line immunotherapies such as anakinra and tocilizumab. Intrathecal dexamethasone is an emerging treatment. Additionally, studies are investigating more targeted immunotherapies based on immunologic profiles. Despite treatment, outcomes remain poor, with high morbidity and mortality. Neurologic sequalae includes intractable epilepsy, functional impairment, mood disorders, and behavioral disturbances. Many patients report poor quality of life.

Summary: NORSE/FIRES is a severe neurologic entity. Research is underway to determine pathogenesis, develop biomarkers, and provide more targeted immunotherapies with hopes of improving patient outcomes.

回顾目的:新发难治性癫痫状态(NORSE)和发热性感染相关癫痫综合征(FIRES)是一种罕见的临床表现,发病迅速,病因不明,病程不可预测,神经系统后遗症长期存在。国际共识建议于2022年发表,以帮助NORSE/FIRES的诊断、治疗和研究。随后,在了解病理生理学和免疫疗法的疗效方面取得了进展。最近的研究发现:越来越多的证据表明,NORSE/FIRES患者存在免疫失调。细胞因子/趋化因子谱可作为指导诊断和治疗的生物标志物。随着二线免疫疗法如anakinra和tocilizumab的使用增加,NORSE/FIRES的治疗前景正在发展。鞘内地塞米松是一种新兴的治疗方法。此外,研究正在研究基于免疫概况的更有针对性的免疫疗法。尽管进行了治疗,但结果仍然很差,发病率和死亡率都很高。神经系统后遗症包括顽固性癫痫、功能损害、情绪障碍和行为障碍。许多患者报告生活质量差。总结:NORSE/FIRES是一种严重的神经系统疾病。研究正在进行中,以确定发病机制,开发生物标志物,并提供更有针对性的免疫疗法,以期改善患者的预后。
{"title":"Update in new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.","authors":"Pooja D Shah, Heather A Voss-Hoynes, Rachel A Pauley","doi":"10.1097/MOP.0000000000001501","DOIUrl":"10.1097/MOP.0000000000001501","url":null,"abstract":"<p><strong>Purpose of review: </strong>New-onset refractory status epileptics (NORSE) and a subset, febrile infection-related epilepsy syndrome (FIRES), are rare clinical presentations with rapid onset, cryptogenic etiology, unpredictable course, and long-standing neurologic sequalae. International consensus recommendations were published in 2022 to aid in diagnosis, treatment, and research of NORSE/FIRES. Subsequently, there have been advances in understanding both the pathophysiology and the efficacy of immunotherapies.</p><p><strong>Recent findings: </strong>There is growing evidence of immune dysregulation in NORSE/FIRES. Cytokine/chemokine profiles may serve as biomarkers to guide diagnosis and management. The treatment landscape for NORSE/FIRES is evolving, with increasing use of second-line immunotherapies such as anakinra and tocilizumab. Intrathecal dexamethasone is an emerging treatment. Additionally, studies are investigating more targeted immunotherapies based on immunologic profiles. Despite treatment, outcomes remain poor, with high morbidity and mortality. Neurologic sequalae includes intractable epilepsy, functional impairment, mood disorders, and behavioral disturbances. Many patients report poor quality of life.</p><p><strong>Summary: </strong>NORSE/FIRES is a severe neurologic entity. Research is underway to determine pathogenesis, develop biomarkers, and provide more targeted immunotherapies with hopes of improving patient outcomes.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"550-554"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-life viral infections and asthma: new cells and ideas. 生命早期的病毒感染和哮喘:新的细胞和想法。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-06 DOI: 10.1097/MOP.0000000000001514
Jie Lan, Alysia McCray, Emma Brown, Taylor Eddens

Purpose of review: Asthma is among the most common conditions managed by pediatricians. This review summarizes recent advances in our immunologic understanding of asthma, focusing on cell types implicated in pathogenesis outside of the Th2 paradigm. Early-life respiratory viral infections are a key risk factor for the development of pediatric asthma. Literature detailing the epidemiologic and immunologic connection between early-life viral infections and asthma is also reviewed.

Recent findings: Asthma is an umbrella term used clinically, but the underlying immune mechanisms can be highly variable. These differing endotypes of asthma can be driven by distinct granulocyte, CD4 + T-cell, and innate-cell subsets, all with therapeutic implications. Early-life viral infection is a well described risk factor for asthma development. Understanding the differences in the immune system early in life, focused on the lung milieu, has shed light on the mechanisms connecting these two conditions.

Summary: Early-life respiratory viral infections and asthma have high prevalence in pediatrics, with the former raising the risk for the latter. Understanding the immunologic mechanisms is critical in understanding this connection. Further, our understanding of the drivers of asthma in pediatrics has expanded beyond the canonical pathways.

综述目的:哮喘是儿科医生治疗的最常见疾病之一。这篇综述总结了我们对哮喘的免疫学理解的最新进展,重点是在Th2范式之外涉及发病机制的细胞类型。生命早期呼吸道病毒感染是儿童哮喘发展的关键危险因素。文献详细的流行病学和免疫学联系之间的早期生活病毒感染和哮喘也进行了审查。最近的发现:哮喘是临床使用的一个总称,但潜在的免疫机制可能是高度可变的。这些不同的哮喘内型可由不同的粒细胞、CD4 + t细胞和先天细胞亚群驱动,所有这些都具有治疗意义。生命早期病毒感染是哮喘发展的一个很好的危险因素。了解生命早期免疫系统的差异,重点关注肺部环境,揭示了连接这两种疾病的机制。摘要:早期呼吸道病毒感染和哮喘在儿科的患病率很高,前者增加了后者的风险。了解免疫机制是理解这种联系的关键。此外,我们对儿科哮喘驱动因素的理解已经超出了规范途径。
{"title":"Early-life viral infections and asthma: new cells and ideas.","authors":"Jie Lan, Alysia McCray, Emma Brown, Taylor Eddens","doi":"10.1097/MOP.0000000000001514","DOIUrl":"10.1097/MOP.0000000000001514","url":null,"abstract":"<p><strong>Purpose of review: </strong>Asthma is among the most common conditions managed by pediatricians. This review summarizes recent advances in our immunologic understanding of asthma, focusing on cell types implicated in pathogenesis outside of the Th2 paradigm. Early-life respiratory viral infections are a key risk factor for the development of pediatric asthma. Literature detailing the epidemiologic and immunologic connection between early-life viral infections and asthma is also reviewed.</p><p><strong>Recent findings: </strong>Asthma is an umbrella term used clinically, but the underlying immune mechanisms can be highly variable. These differing endotypes of asthma can be driven by distinct granulocyte, CD4 + T-cell, and innate-cell subsets, all with therapeutic implications. Early-life viral infection is a well described risk factor for asthma development. Understanding the differences in the immune system early in life, focused on the lung milieu, has shed light on the mechanisms connecting these two conditions.</p><p><strong>Summary: </strong>Early-life respiratory viral infections and asthma have high prevalence in pediatrics, with the former raising the risk for the latter. Understanding the immunologic mechanisms is critical in understanding this connection. Further, our understanding of the drivers of asthma in pediatrics has expanded beyond the canonical pathways.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"597-605"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594164/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence supported facial feature analysis in medical genetics. 人工智能支持医学遗传学中的面部特征分析。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-24 DOI: 10.1097/MOP.0000000000001487
Karen W Gripp

Purpose of review: This review highlights recent developments in the use of machine learning supported facial feature analysis in the context of genetic and syndromic conditions. The review focusses on 2D image-based tools. The 2D images are easily obtained using handheld devices such as mobile phones and are more relevant to general practice than 3D image based systems.

Recent findings: Different algorithms are used widely in pediatric clinics, medical genetics clinics, for gene variant analysis and in research. Integrated systems combining next-generation phenotyping with next-generation genotyping support a shortened diagnostic odyssey for patients.

Summary: Future integration of phenotyping using data available in electronic medical records with genotyping data will likely result in earlier identification of possible genetic conditions.

综述目的:本综述重点介绍了在遗传和综合征条件下使用机器学习支持面部特征分析的最新进展。本文的重点是基于2D图像的工具。2D图像很容易使用手持设备(如移动电话)获得,并且比基于3D图像的系统更符合一般实践。最新发现:不同的算法被广泛应用于儿科诊所、医学遗传学诊所、基因变异分析和研究。集成系统结合下一代表型与下一代基因分型支持缩短诊断奥德赛患者。摘要:未来将电子病历中可用的表型分析数据与基因分型数据整合起来,可能会导致更早地识别可能的遗传状况。
{"title":"Artificial intelligence supported facial feature analysis in medical genetics.","authors":"Karen W Gripp","doi":"10.1097/MOP.0000000000001487","DOIUrl":"https://doi.org/10.1097/MOP.0000000000001487","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights recent developments in the use of machine learning supported facial feature analysis in the context of genetic and syndromic conditions. The review focusses on 2D image-based tools. The 2D images are easily obtained using handheld devices such as mobile phones and are more relevant to general practice than 3D image based systems.</p><p><strong>Recent findings: </strong>Different algorithms are used widely in pediatric clinics, medical genetics clinics, for gene variant analysis and in research. Integrated systems combining next-generation phenotyping with next-generation genotyping support a shortened diagnostic odyssey for patients.</p><p><strong>Summary: </strong>Future integration of phenotyping using data available in electronic medical records with genotyping data will likely result in earlier identification of possible genetic conditions.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":"37 6","pages":"533-537"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of social determinants of health in the developing injured brain. 健康的社会决定因素在发育中的受伤大脑中的作用。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-01 DOI: 10.1097/MOP.0000000000001505
Danielle Clifford, Brian H Walsh, Deirdre M Murray

Purpose of review: We provide a comprehensive review of the evidence on the influence social determinants of health play in the most common causes of perinatal brain injury. This area remains under-investigated, and the evidence can be difficult to navigate.

Recent findings: There is strong emerging evidence on factors such as the influence of maternal education, and in particular a cognitively stimulating home environment, on the language development of preterm infants. The role of the home environment on children following hypoxic brain injury and congenital heart disease is less well studied.

Summary: The social determinants of the child's home environment have a significant additive effect on the perinatal risk of a child on later development, particularly their language development.

综述的目的:我们提供了一个全面的证据对影响健康的社会决定因素发挥围产期脑损伤的最常见原因。这一领域仍未得到充分调查,证据可能难以把握。最近的发现:有强有力的新证据表明,诸如母亲教育,特别是刺激认知的家庭环境对早产儿语言发展的影响等因素。家庭环境对儿童缺氧脑损伤和先天性心脏病的影响研究较少。摘要:儿童家庭环境的社会决定因素对儿童后期发展的围产期风险有显著的叠加效应,特别是他们的语言发展。
{"title":"The role of social determinants of health in the developing injured brain.","authors":"Danielle Clifford, Brian H Walsh, Deirdre M Murray","doi":"10.1097/MOP.0000000000001505","DOIUrl":"10.1097/MOP.0000000000001505","url":null,"abstract":"<p><strong>Purpose of review: </strong>We provide a comprehensive review of the evidence on the influence social determinants of health play in the most common causes of perinatal brain injury. This area remains under-investigated, and the evidence can be difficult to navigate.</p><p><strong>Recent findings: </strong>There is strong emerging evidence on factors such as the influence of maternal education, and in particular a cognitively stimulating home environment, on the language development of preterm infants. The role of the home environment on children following hypoxic brain injury and congenital heart disease is less well studied.</p><p><strong>Summary: </strong>The social determinants of the child's home environment have a significant additive effect on the perinatal risk of a child on later development, particularly their language development.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"570-576"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of the child with primary immunodeficiency. 原发性免疫缺陷儿童的管理。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-24 DOI: 10.1097/MOP.0000000000001513
Heather K Lehman, Anushka Khaira, Simranjit Kaur

Purpose of review: The purpose of this review is to provide an update on monitoring, prevention, and treatment of infectious and noninfectious complications of phagocytic, humoral, and cellular immune deficiencies.

Recent findings: The recognition that immune dysregulatory features are hallmarks of many genetic defects leading to immune deficiency have led to a new name for all congenital disorders that primarily impact immune function - inborn errors of immunity (IEI). While controlling infections is critical for treatment of patients with IEI, recognition and management of noninfectious complications should also be a focus of comprehensive management of these conditions. Major advances in use of definitive therapies including hematopoietic stem cell transplant, gene therapy, and gene editing have allowed for improved outcomes in cellular and phagocytic immune defects.

Summary: There are now over 550 identified IEI, and effective management of these conditions requires a multidisciplinary approach to monitoring, preventing, and treating both infectious and noninfectious complications of IEI.

综述目的:本综述的目的是提供吞噬、体液和细胞免疫缺陷的感染性和非感染性并发症的监测、预防和治疗的最新进展。最近的发现:认识到免疫失调特征是许多导致免疫缺陷的遗传缺陷的标志,这导致了对所有主要影响免疫功能的先天性疾病的新名称-先天性免疫错误(IEI)。虽然控制感染对IEI患者的治疗至关重要,但非感染性并发症的识别和管理也应成为这些疾病综合管理的重点。包括造血干细胞移植、基因治疗和基因编辑在内的决定性疗法的使用取得了重大进展,从而改善了细胞和吞噬性免疫缺陷的治疗结果。总结:目前确诊的IEI超过550例,对这些病症的有效管理需要多学科方法来监测、预防和治疗IEI的传染性和非传染性并发症。
{"title":"Management of the child with primary immunodeficiency.","authors":"Heather K Lehman, Anushka Khaira, Simranjit Kaur","doi":"10.1097/MOP.0000000000001513","DOIUrl":"https://doi.org/10.1097/MOP.0000000000001513","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to provide an update on monitoring, prevention, and treatment of infectious and noninfectious complications of phagocytic, humoral, and cellular immune deficiencies.</p><p><strong>Recent findings: </strong>The recognition that immune dysregulatory features are hallmarks of many genetic defects leading to immune deficiency have led to a new name for all congenital disorders that primarily impact immune function - inborn errors of immunity (IEI). While controlling infections is critical for treatment of patients with IEI, recognition and management of noninfectious complications should also be a focus of comprehensive management of these conditions. Major advances in use of definitive therapies including hematopoietic stem cell transplant, gene therapy, and gene editing have allowed for improved outcomes in cellular and phagocytic immune defects.</p><p><strong>Summary: </strong>There are now over 550 identified IEI, and effective management of these conditions requires a multidisciplinary approach to monitoring, preventing, and treating both infectious and noninfectious complications of IEI.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":"37 6","pages":"606-612"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145444230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic drivers of care disparity among patients with inborn errors of immunity. 先天性免疫缺陷患者护理差异的社会人口驱动因素。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-09-12 DOI: 10.1097/MOP.0000000000001506
Caitlin M Neary, Mei-Sing Ong, Jocelyn R Farmer

Purpose of review: To review the current literature surrounding impact of sociodemographic factors, including race, ethnicity, and socioeconomic status, on care disparities for inborn errors of immunity (IEI).

Recent findings: There is a growing body of literature indicating significant sociodemographic and geographical disparities in diagnosis, management, and clinical outcomes of IEI. Historically underserved populations are more likely to experience underdiagnosis, diagnostic delay, and more severe adverse health events, including more infections and earlier death. Implementation of universal newborn screening and no-cost genetic testing programs have helped address the cost barriers to early diagnosis, representing important steps towards addressing diagnostic disparities in IEI. In parallel, recent advances in artificial intelligence offer promise by enhancing identification of IEI through automated analysis of clinical data. However, significant disparities remain.

Summary: This review highlights sociodemographic drivers of care disparities for IEI. More inclusive screening and diagnostic tools, such as use of unbiased molecular and artificial intelligence approaches, may offer critical opportunities to close these gaps for these most vulnerable IEI patient populations.

综述目的:回顾目前有关社会人口因素(包括种族、民族和社会经济地位)对先天性免疫错误(IEI)护理差异影响的文献。最近的发现:越来越多的文献表明,在IEI的诊断、管理和临床结果方面存在显著的社会人口统计学和地理差异。历史上服务不足的人群更有可能经历诊断不足、诊断延误和更严重的不良健康事件,包括更多的感染和更早的死亡。普遍新生儿筛查和免费基因检测项目的实施有助于解决早期诊断的成本障碍,这是解决IEI诊断差异的重要步骤。与此同时,人工智能的最新进展通过自动分析临床数据来增强对IEI的识别,这为我们带来了希望。然而,巨大的差距仍然存在。摘要:本综述强调了IEI护理差异的社会人口学驱动因素。更具包容性的筛查和诊断工具,例如使用无偏见的分子和人工智能方法,可能为这些最脆弱的IEI患者群体提供缩小这些差距的关键机会。
{"title":"Sociodemographic drivers of care disparity among patients with inborn errors of immunity.","authors":"Caitlin M Neary, Mei-Sing Ong, Jocelyn R Farmer","doi":"10.1097/MOP.0000000000001506","DOIUrl":"10.1097/MOP.0000000000001506","url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the current literature surrounding impact of sociodemographic factors, including race, ethnicity, and socioeconomic status, on care disparities for inborn errors of immunity (IEI).</p><p><strong>Recent findings: </strong>There is a growing body of literature indicating significant sociodemographic and geographical disparities in diagnosis, management, and clinical outcomes of IEI. Historically underserved populations are more likely to experience underdiagnosis, diagnostic delay, and more severe adverse health events, including more infections and earlier death. Implementation of universal newborn screening and no-cost genetic testing programs have helped address the cost barriers to early diagnosis, representing important steps towards addressing diagnostic disparities in IEI. In parallel, recent advances in artificial intelligence offer promise by enhancing identification of IEI through automated analysis of clinical data. However, significant disparities remain.</p><p><strong>Summary: </strong>This review highlights sociodemographic drivers of care disparities for IEI. More inclusive screening and diagnostic tools, such as use of unbiased molecular and artificial intelligence approaches, may offer critical opportunities to close these gaps for these most vulnerable IEI patient populations.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"613-618"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145039470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From tradition to transformation: evolving models of care in clinical genetics. 从传统到转变:临床遗传学护理的演变模式。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-08-20 DOI: 10.1097/MOP.0000000000001502
Helen Curd, Anita Gorrie, Andrew Paul Fennell

Purpose of review: The integration of genomics into mainstream healthcare is transforming clinical genetics into a foundational component of modern medicine. This review explores the evolution of clinical genetics service delivery, highlighting evolving models of care designed to meet rising demand, improve access, and ensure equitable, patient-centered genomic care.

Recent findings: Key models of care discussed include multidisciplinary team approaches, embedded genetic counselors, advanced practice providers, upskilled non-genetics specialists, laboratory-based genetics clinicians, primary care providers of genetic healthcare and automated/patient-directed models. Educational needs, funding and adjuncts such as genetic assistants, collaborative telegenetics, and digital tools are also discussed for their role in supporting sustainable implementation.

Summary: We recommend health organizations develop a roadmap for genomic medicine through creation of a genomic medicine governance framework, assessment of workforce capacity, definition of patient cohorts, and reviewing their infrastructure readiness. No single model of care is suitable for every context. By clearly defining needs, acknowledging limitations, and identifying potential risks, organizations can select the most appropriate models to address both current and future requirements. As genomics becomes increasingly embedded in routine care, we believe a coordinated, evidence-based approach is essential to ensure well tolerated, effective, accessible, equitable, and sustainable delivery of genomic medicine across diverse healthcare settings.

综述目的:基因组学与主流医疗保健的整合正在将临床遗传学转变为现代医学的基础组成部分。本综述探讨了临床遗传学服务提供的演变,强调了旨在满足不断增长的需求、改善获取和确保公平、以患者为中心的基因组护理的不断发展的护理模式。讨论的主要护理模式包括多学科团队方法、嵌入式遗传咨询师、高级实践提供者、高技能的非遗传学专家、基于实验室的遗传学临床医生、遗传保健的初级保健提供者和自动化/患者导向模型。还讨论了教育需求、资金和辅助工具(如遗传助理、协作远程遗传和数字工具)在支持可持续实施方面的作用。摘要:我们建议卫生组织通过创建基因组医学治理框架、评估工作人员能力、定义患者队列和审查其基础设施准备情况来制定基因组医学路线图。没有一种护理模式适合所有情况。通过明确定义需求、承认限制和识别潜在风险,组织可以选择最合适的模型来处理当前和未来的需求。随着基因组学越来越多地嵌入到日常护理中,我们相信,一种协调的、基于证据的方法对于确保在不同的医疗保健环境中提供良好的耐受性、有效性、可及性、公平和可持续的基因组医学至关重要。
{"title":"From tradition to transformation: evolving models of care in clinical genetics.","authors":"Helen Curd, Anita Gorrie, Andrew Paul Fennell","doi":"10.1097/MOP.0000000000001502","DOIUrl":"10.1097/MOP.0000000000001502","url":null,"abstract":"<p><strong>Purpose of review: </strong>The integration of genomics into mainstream healthcare is transforming clinical genetics into a foundational component of modern medicine. This review explores the evolution of clinical genetics service delivery, highlighting evolving models of care designed to meet rising demand, improve access, and ensure equitable, patient-centered genomic care.</p><p><strong>Recent findings: </strong>Key models of care discussed include multidisciplinary team approaches, embedded genetic counselors, advanced practice providers, upskilled non-genetics specialists, laboratory-based genetics clinicians, primary care providers of genetic healthcare and automated/patient-directed models. Educational needs, funding and adjuncts such as genetic assistants, collaborative telegenetics, and digital tools are also discussed for their role in supporting sustainable implementation.</p><p><strong>Summary: </strong>We recommend health organizations develop a roadmap for genomic medicine through creation of a genomic medicine governance framework, assessment of workforce capacity, definition of patient cohorts, and reviewing their infrastructure readiness. No single model of care is suitable for every context. By clearly defining needs, acknowledging limitations, and identifying potential risks, organizations can select the most appropriate models to address both current and future requirements. As genomics becomes increasingly embedded in routine care, we believe a coordinated, evidence-based approach is essential to ensure well tolerated, effective, accessible, equitable, and sustainable delivery of genomic medicine across diverse healthcare settings.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"538-549"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transition of care for adolescents and young adults with neurodevelopmental disorders. 有神经发育障碍的青少年和年轻成人护理的过渡。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-10 DOI: 10.1097/MOP.0000000000001518
Andres Jimenez-Gomez, Angel Aledo-Serrano, Rima Nabbout

Purpose of review: The increasing prevalence of neurodevelopmental disorders (NDDs) in adolescents and adults in recent decades is changing the paradigms of care provision across specialties, including pediatric and adult primary care and specialty services such as neurology. Transition into adulthood and transfer to adult care providers remains an underdeveloped area of care and research.

Recent findings: The transition process requires significant coordination of care between the family and multiple medical and nonmedical providers as well as community entities. This articulation occurs at times integrated into the continuity of care within certain specialty clinics (i.e. transition programs). There are often additional layers of complexity with NDDs where there are multiple comorbidities, that require synchronous care under transition clinics, addressing medical and psychosocial, educational, vocational, and financial issues (among others). The significant complexity is often compounded with individual and family resistance to change, emotional distress, and feelings of societal disconnect resulting in suboptimal care.

Summary: There are emerging models to address transition and transfer of care into adulthood for individuals with NDDs. However, given the challenges and potential points for disenfranchisement, additional research into uniform models that adapt to condition complexity, local and regional resources, are necessary.

综述目的:近几十年来,神经发育障碍(ndd)在青少年和成人中日益流行,正在改变各专科的护理模式,包括儿科和成人初级保健以及神经病学等专科服务。过渡到成年和转移到成人护理提供者仍然是一个不发达的护理和研究领域。最近的发现:过渡过程需要在家庭和多个医疗和非医疗提供者以及社区实体之间进行重大的护理协调。这种衔接有时会被整合到某些专科诊所(即过渡项目)的连续性护理中。在有多种合并症的情况下,ndd往往存在额外的复杂性,需要在过渡诊所进行同步护理,解决医疗和社会心理、教育、职业和财务问题(以及其他问题)。这种显著的复杂性往往与个人和家庭对改变的抵制、情绪困扰和社会脱节的感觉相结合,导致护理效果欠佳。总结:有一些新兴的模式来解决ndd患者成年期护理的过渡和转移。然而,考虑到面临的挑战和剥夺公民权的潜在问题,有必要进一步研究适应条件复杂性、当地和区域资源的统一模型。
{"title":"Transition of care for adolescents and young adults with neurodevelopmental disorders.","authors":"Andres Jimenez-Gomez, Angel Aledo-Serrano, Rima Nabbout","doi":"10.1097/MOP.0000000000001518","DOIUrl":"10.1097/MOP.0000000000001518","url":null,"abstract":"<p><strong>Purpose of review: </strong>The increasing prevalence of neurodevelopmental disorders (NDDs) in adolescents and adults in recent decades is changing the paradigms of care provision across specialties, including pediatric and adult primary care and specialty services such as neurology. Transition into adulthood and transfer to adult care providers remains an underdeveloped area of care and research.</p><p><strong>Recent findings: </strong>The transition process requires significant coordination of care between the family and multiple medical and nonmedical providers as well as community entities. This articulation occurs at times integrated into the continuity of care within certain specialty clinics (i.e. transition programs). There are often additional layers of complexity with NDDs where there are multiple comorbidities, that require synchronous care under transition clinics, addressing medical and psychosocial, educational, vocational, and financial issues (among others). The significant complexity is often compounded with individual and family resistance to change, emotional distress, and feelings of societal disconnect resulting in suboptimal care.</p><p><strong>Summary: </strong>There are emerging models to address transition and transfer of care into adulthood for individuals with NDDs. However, given the challenges and potential points for disenfranchisement, additional research into uniform models that adapt to condition complexity, local and regional resources, are necessary.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"577-584"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetal neurology: evolving roles for pediatricians and neurologists in prenatal and postnatal care. 胎儿神经病学:儿科医生和神经科医生在产前和产后护理中的角色演变。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-09-24 DOI: 10.1097/MOP.0000000000001511
Laura E Vernon, Andrea C Pardo

Purpose of review: Fetal neurology is a distinct subspecialty within pediatric neurology, and a core element of neonatal neurocritical care. Increased fidelity and availability of fetal imaging and increasing yields of advanced genetic testing help the fetal neurologist provide an assessment of potential neurodevelopmental outcomes when a suspected or confirmed fetal brain malformation is present. The postnatal care of infants with a previously diagnosed brain abnormality may include pediatricians in a general primary care setting. It is imperative that pediatricians have a basic understanding of common fetal neurologic conditions and comorbidities to provide the best care to new families facing these challenges.

Recent findings: Growing literature of fetal brain abnormalities has allowed for increasing prenatal neurologic diagnoses. The recent recognition of neonatal neurocritical care as a distinct subspecialty seeks to optimize the management and care of this patient population.

Summary: This review provides a broad overview of the evolution of fetal neurology as a distinct field within neurology and neonatal neurocritical care. This article highlights nuances of fetal consultations and reviews some of the more common fetal neurologic diagnoses and comorbidities. Finally, it provides a call to action for collaborative management in pediatric care.

综述目的:胎儿神经病学是儿科神经病学中一个独特的亚专科,也是新生儿神经危重症护理的核心内容。胎儿成像的保真度和可用性的提高,以及先进基因检测的增加,有助于胎儿神经科医生在怀疑或确认胎儿脑畸形时,对潜在的神经发育结果进行评估。产后护理的婴儿与先前诊断的脑异常可能包括儿科医生在一般初级保健设置。儿科医生必须对常见的胎儿神经系统疾病和合并症有一个基本的了解,以便为面临这些挑战的新家庭提供最好的护理。最近的发现:越来越多的胎儿大脑异常的文献允许增加产前神经学诊断。最近认识到新生儿神经危重症护理作为一个独特的亚专科寻求优化管理和护理这一患者群体。摘要:这篇综述提供了胎儿神经病学作为神经病学和新生儿神经危重症护理的一个独特领域的发展的广泛概述。这篇文章强调胎儿咨询的细微差别,并回顾了一些更常见的胎儿神经系统诊断和合并症。最后,它为儿科护理的协作管理提供了行动呼吁。
{"title":"Fetal neurology: evolving roles for pediatricians and neurologists in prenatal and postnatal care.","authors":"Laura E Vernon, Andrea C Pardo","doi":"10.1097/MOP.0000000000001511","DOIUrl":"10.1097/MOP.0000000000001511","url":null,"abstract":"<p><strong>Purpose of review: </strong>Fetal neurology is a distinct subspecialty within pediatric neurology, and a core element of neonatal neurocritical care. Increased fidelity and availability of fetal imaging and increasing yields of advanced genetic testing help the fetal neurologist provide an assessment of potential neurodevelopmental outcomes when a suspected or confirmed fetal brain malformation is present. The postnatal care of infants with a previously diagnosed brain abnormality may include pediatricians in a general primary care setting. It is imperative that pediatricians have a basic understanding of common fetal neurologic conditions and comorbidities to provide the best care to new families facing these challenges.</p><p><strong>Recent findings: </strong>Growing literature of fetal brain abnormalities has allowed for increasing prenatal neurologic diagnoses. The recent recognition of neonatal neurocritical care as a distinct subspecialty seeks to optimize the management and care of this patient population.</p><p><strong>Summary: </strong>This review provides a broad overview of the evolution of fetal neurology as a distinct field within neurology and neonatal neurocritical care. This article highlights nuances of fetal consultations and reviews some of the more common fetal neurologic diagnoses and comorbidities. Finally, it provides a call to action for collaborative management in pediatric care.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"564-569"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early recognition of status dystonicus in children: a case-based approach for the general pediatrician. 儿童状态障碍的早期识别:普通儿科医生的病例为基础的方法。
IF 2.5 3区 医学 Q2 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-09-18 DOI: 10.1097/MOP.0000000000001507
Ann L Robbins, Kathryn Yang, Darius Ebrahimi-Fakhari, Jennifer A O'Malley

Purpose of review: This review highlights the importance of promptly recognizing and correctly naming status dystonicus as a neurologic emergency in the outpatient and inpatient settings, and aims to equip general pediatricians with practical guidance to trigger rapid escalation of care through the recently published status dystonicus pathways.

Recent findings: In 2024, Vogt et al. introduced two consensus algorithms - the acute dystonia pathway and the refractory status dystonicus pathway - aimed to unify diagnostic criteria, triage steps, and staged pharmacological and supportive interventions for status dystonicus across healthcare environments.

Summary: Effective application of these pathways empowers frontline clinicians to identify status dystonicus early, initiate first-line treatments without delay, and expedite transfer to specialized teams, thereby reducing the morbidity and mortality associated with this life-threatening movement disorder emergency.

综述目的:本综述强调了在门诊和住院环境中及时识别和正确命名肌张力障碍状态作为神经系统急症的重要性,旨在通过最近发表的肌张力障碍状态通路为普通儿科医生提供实用指导,以触发快速升级的护理。最近的发现:在2024年,Vogt等人引入了两种共识算法——急性肌张力障碍途径和难治性肌张力障碍途径——旨在统一医疗环境中肌张力障碍的诊断标准、分诊步骤和阶段性药理和支持性干预措施。总结:这些途径的有效应用使一线临床医生能够及早识别肌张力障碍状态,立即开始一线治疗,并迅速转移到专业团队,从而降低与这种危及生命的运动障碍紧急情况相关的发病率和死亡率。
{"title":"Early recognition of status dystonicus in children: a case-based approach for the general pediatrician.","authors":"Ann L Robbins, Kathryn Yang, Darius Ebrahimi-Fakhari, Jennifer A O'Malley","doi":"10.1097/MOP.0000000000001507","DOIUrl":"10.1097/MOP.0000000000001507","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights the importance of promptly recognizing and correctly naming status dystonicus as a neurologic emergency in the outpatient and inpatient settings, and aims to equip general pediatricians with practical guidance to trigger rapid escalation of care through the recently published status dystonicus pathways.</p><p><strong>Recent findings: </strong>In 2024, Vogt et al. introduced two consensus algorithms - the acute dystonia pathway and the refractory status dystonicus pathway - aimed to unify diagnostic criteria, triage steps, and staged pharmacological and supportive interventions for status dystonicus across healthcare environments.</p><p><strong>Summary: </strong>Effective application of these pathways empowers frontline clinicians to identify status dystonicus early, initiate first-line treatments without delay, and expedite transfer to specialized teams, thereby reducing the morbidity and mortality associated with this life-threatening movement disorder emergency.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":" ","pages":"555-563"},"PeriodicalIF":2.5,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current opinion in pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1